Arthrex PushLock

K173240 · Arthrex, Inc. · MAI · Jan 16, 2018 · Orthopedic

Device Facts

• Record ID: K173240
• Device Name: Arthrex PushLock
• Applicant: Arthrex, Inc.
• Product Code: MAI · Orthopedic
• Decision Date: Jan 16, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The 2.5mm Arthrex Mini Bio-PushLock is intended to be used for suture or tissue fixation in the foot, ankle, knee, hand, wrist, elbow, shoulder, and hip. Specific indications are listed below: Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament Reconstruction Shoulder: Rotator Cuff Repairs, Bankart Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction Hand/Wrist: Scapholunate Ligament Reconstruction, Carpal Ligament Reconstructions, Repair/Reconstruction of collateral ligaments, Repair of Flexor and Extensor Tendons at the PIP, DIP, and MCP joints for all digits, Digital Tendon Transfers Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Metatarsal Ligament Repair, Hallux Valgus reconstruction, Digital Tendon Transfers, Mid-foot Reconstruction Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis The 2.9mm BioComposite PushLock is intended to be used for suture or tissue fixation in the foot, ankle, knee, hand, wrist, elbow, shoulder, and hip. Specific indications are listed below: Elbow: Bicens Tendon Reattachment, Tennis Elbow Repair.Unar or Radial Collateral Ligament Reconstruction, Lateral Epicondylitis Repair Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Metatarsal Ligament Repair, Hallux Valgus reconstruction, Digital Tendon Transfers, Mid-foot Reconstruction, Bunionectomy Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis Hip: Capsular Repair, Acetabular Labral repair

Device Story

Two-piece push-in suture anchor; biodegradable anchor body (PLLA or PLDLA/βTCP) with PEEK eyelet; pre-loaded on disposable inserter. Used by orthopedic surgeons in clinical settings for soft tissue fixation to bone. Device secures sutures to anchor tissue during reconstructive procedures. Shelf-life expansion from 2 to 4 years.

Clinical Evidence

Bench testing only. Inherent viscosity and minimum peak load testing performed after 4-year shelf-life aging. Bacterial endotoxin testing per EP 2.6.14/USP <85> confirms compliance with pyrogen limit specifications.

Technological Characteristics

Two-piece push-in suture anchor; 2.5mm-2.9mm diameter; 8mm-15.5mm length. Materials: PLLA or PLDLA/βTCP anchor body, PEEK eyelet. Disposable inserter included. Non-active, mechanical fixation device.

Indications for Use

Indicated for suture or tissue fixation in foot, ankle, knee, hand, wrist, elbow, shoulder, and hip for patients requiring ligament, tendon, or capsular repair/reconstruction.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• Arthrex PushLock (K063479)
• Arthrex PushLock (K101679)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains two logos. The logo on the left is the Department of Health & Human Services - USA logo. The logo on the right is the FDA U.S. Food & Drug Administration logo. The FDA logo is in blue.

January 16, 2018

Arthrex Inc. David L. Rogers Project Manager, Regulatory Affairs 1370 Creekside Boulevard Naples, Florida 34108-1945

Re: K173240

Trade/Device Name: Arthrex PushLock Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: MAI Dated: July 21, 2017 Received: October 18, 2017

Dear Mr. Rogers:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510(k) Number (if known)

#### K173240

Device Name Arthrex PushLock

#### Indications for Use (Describe)

The 2.5mm Arthrex Mini Bio-PushLock is intended to be used for suture or tissue fixation in the foot, ankle, knee, hand, wrist, elbow, shoulder, and hip. Specific indications are listed below:

Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament Reconstruction

Shoulder: Rotator Cuff Repairs, Bankart Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction

Hand/Wrist: Scapholunate Ligament Reconstruction, Carpal Ligament Reconstructions, Repair/Reconstruction of collateral ligaments, Repair of Flexor and Extensor Tendons at the PIP, DIP, and MCP joints for all digits, Digital Tendon Transfers

Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Metatarsal Ligament Repair, Hallux Valgus reconstruction, Digital Tendon Transfers, Mid-foot Reconstruction

Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis

The 2.9mm BioComposite PushLock is intended to be used for suture or tissue fixation in the foot, ankle, knee, hand, wrist, elbow, shoulder, and hip. Specific indications are listed below:

Elbow: Bicens Tendon Reattachment, Tennis Elbow Repair.Unar or Radial Collateral Ligament Reconstruction, Lateral Epicondylitis Repair

Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction

Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction

Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Metatarsal Ligament Repair, Hallux Valgus reconstruction, Digital Tendon Transfers, Mid-foot Reconstruction, Bunionectomy

Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis

Hip: Capsular Repair, Acetabular Labral repair

Type of Use (Select one or both, as applicable)

* | Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

{3}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.qov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

## 510(k) Summary

| Date Prepared | July 21, 2017 |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter | Arthrex Inc. |
| | 1370 Creekside Boulevard |
| | Naples, FL 34108-1945 |
| Contact Person | David L Rogers |
| | Project Manager, Regulatory Affairs |
| | 1-239-643-5553, ext. 71924 |
| | [e-mail] |
| Name of Device | Arthrex PushLock |
| Common Name | Suture Anchor |
| Product Code | MAI |
| Classification Name | 21 CFR 888.3030: Fastener, Fixation, Biodegradable, Soft Tissue |
| Regulatory Class | = |
| Predicate Device | K063479: Arthrex PushLock |
| | K101679: Arthrex PushLock |
| Purpose of | This traditional 510(k) premarket notification is submitted to expand the shelf-life |
| Submission | for the bioabsorbable Arthrex PushLocks cleared under K063479 and K101679 |
| | from 2 years to 4 years. |
| | |
| Device Description | The Arthrex PushLock is a two piece "push-in" suture anchor device comprising a |
| | biodegradable anchor body manufactured from either PLLA or PLDLA/βTCP with |
| | a polyetheretherketone (PEEK) eyelet pre-loaded on a disposable inserter. The |
| | anchor body ranges in diameter from 2.5mm to 2.9mm and 8mm to 15.5mm in |
| | length. |
| | |
| Indications for Use | The 2.5mm Arthrex PushLock is intended to be used for suture or tissue fixation |
| | in the foot, ankle, knee, hand, wrist, elbow, shoulder, and hip. Specific |
| | indications are listed below: |
| | Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament<br>● |
| | Reconstruction<br>Shoulder: Rotator Cuff Repairs, Bankart Repair, SLAP Lesion Repair, |
| | ●<br>Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, |
| | Capsular Shift or Capsulolabral Reconstruction |
| | Hand/Wrist: Scapholunate Ligament Reconstruction, Carpal Ligament<br>● |
| | Reconstructions, Repair/Reconstruction of collateral ligaments, Repair of |
| | Flexor and Extensor Tendons at the PIP, DIP, and MCP joints for all digits, |
| | Digital Tendon Transfers |
| | Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon<br>● |
| | Repair, Metatarsal Ligament Repair, Hallux Valgus reconstruction, Digital |
| | Tendon Transfers, Mid-foot Reconstruction |
| | Knee: Medial Collateral Ligament Repair, Lateral Collateral Ligament<br>● |
| | Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, |
| | Iliotibial Band Tenodesis |
| | |
| | The 2.9mm Arthrex Knotless SutureTak Anchor is intended to be used for suture |
| | or tissue fixation in the foot, ankle, knee, hand, wrist, elbow, shoulder, and hip. |
| | Specific indications are listed below: |
| | Elbow: Biceps Tendon Reattachment, Tennis Elbow Repair, Ulnar or<br>Radial Collateral Ligament Reconstruction, Lateral Epicondylitis Repair Shoulder: Rotator Cuff Repairs, Bankart Repair, SLAP Lesion Repair,<br>Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair,<br>Capsular Shift or Capsulolabral Reconstruction Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial<br>Collateral Ligament Reconstruction Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon<br>Repair, Metatarsal Ligament Repair, Hallux Valgus reconstruction, Digital<br>Tendon Transfers, Mid-foot Reconstruction, Bunionectomy Knee: Medial Collateral Ligament Repair, Lateral Collateral Ligament<br>Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair,<br>Iliotibial Band Tenodesis Hip: Capsular Repair, Acetabular Labral repair |
| Performance Data | Inherent viscosity and minimum peak load testing was performed after four years<br>on the shelf to support the shelf-life expansion to four years.<br><br>Bacterial endotoxin per EP 2.6.14/USP <85> was conducted to demonstrate that<br>the device meets pyrogen limit specifications. |
| Conclusion | The Arthrex PushLock is substantially equivalent to the predicate devices in which<br>the basic design features and intended uses are the same. The subject devices<br>have already been FDA cleared under predicates K063479 and K101679. The only<br>modification presented in this submission is the expansion of the device shelf-life<br>from two years to four years. Any differences between the proposed device and<br>the predicate device are considered minor and do not raise questions concerning<br>safety or effectiveness.<br><br>Based on the indications for use, technological characteristics, and the summary<br>of data submitted, Arthrex Inc. has determined that the proposed device is<br>substantially equivalent to the currently marketed predicate device. |

{5}------------------------------------------------